These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14625288)

  • 1. c-Jun-NH2 kinase (JNK) contributes to the regulation of c-Myc protein stability.
    Alarcon-Vargas D; Ronai Z
    J Biol Chem; 2004 Feb; 279(6):5008-16. PubMed ID: 14625288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The platelet-derived growth factor controls c-myc expression through a JNK- and AP-1-dependent signaling pathway.
    Iavarone C; Catania A; Marinissen MJ; Visconti R; Acunzo M; Tarantino C; Carlomagno MS; Bruni CB; Gutkind JS; Chiariello M
    J Biol Chem; 2003 Dec; 278(50):50024-30. PubMed ID: 14523011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.
    Zhang Y; Neo SY; Wang X; Han J; Lin SC
    J Biol Chem; 1999 Dec; 274(49):35247-54. PubMed ID: 10575011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of the c-JUN-JNK complex by a cell-permeable peptide containing the c-JUN delta domain induces apoptosis and affects a distinct set of interleukin-1-induced inflammatory genes.
    Holzberg D; Knight CG; Dittrich-Breiholz O; Schneider H; Dörrie A; Hoffmann E; Resch K; Kracht M
    J Biol Chem; 2003 Oct; 278(41):40213-23. PubMed ID: 12832416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38.
    Lu X; Nemoto S; Lin A
    J Biol Chem; 1997 Oct; 272(40):24751-4. PubMed ID: 9312068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMO-1 modification of the C-terminal KVEKVD of Axin is required for JNK activation but has no effect on Wnt signaling.
    Rui HL; Fan E; Zhou HM; Xu Z; Zhang Y; Lin SC
    J Biol Chem; 2002 Nov; 277(45):42981-6. PubMed ID: 12223491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase.
    Noguchi K; Kitanaka C; Yamana H; Kokubu A; Mochizuki T; Kuchino Y
    J Biol Chem; 1999 Nov; 274(46):32580-7. PubMed ID: 10551811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of c-myc stability by selective stress conditions and by MEKK1 requires aa 127-189 of c-myc.
    Alarcon-Vargas D; Tansey WP; Ronai Z
    Oncogene; 2002 Jun; 21(28):4384-91. PubMed ID: 12080469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axin utilizes distinct regions for competitive MEKK1 and MEKK4 binding and JNK activation.
    Luo W; Ng WW; Jin LH; Ye Z; Han J; Lin SC
    J Biol Chem; 2003 Sep; 278(39):37451-8. PubMed ID: 12878610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.
    Ortega-Pérez I; Cano E; Were F; Villar M; Vázquez J; Redondo JM
    J Biol Chem; 2005 May; 280(21):20867-78. PubMed ID: 15743762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK.
    Naumann M; Bech-Otschir D; Huang X; Ferrell K; Dubiel W
    J Biol Chem; 1999 Dec; 274(50):35297-300. PubMed ID: 10585392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cells.
    Cui J; Wang Q; Wang J; Lv M; Zhu N; Li Y; Feng J; Shen B; Zhang J
    Mol Cancer Ther; 2009 Dec; 8(12):3214-22. PubMed ID: 19996270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling.
    Sprowles A; Wisdom R
    Oncogene; 2003 Jan; 22(4):498-506. PubMed ID: 12555063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.
    Buschmann T; Potapova O; Bar-Shira A; Ivanov VN; Fuchs SY; Henderson S; Fried VA; Minamoto T; Alarcon-Vargas D; Pincus MR; Gaarde WA; Holbrook NJ; Shiloh Y; Ronai Z
    Mol Cell Biol; 2001 Apr; 21(8):2743-54. PubMed ID: 11283254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the JNK pathway by distantly related protein kinases, MEKK and MUK.
    Hirai S; Izawa M; Osada S; Spyrou G; Ohno S
    Oncogene; 1996 Feb; 12(3):641-50. PubMed ID: 8637721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of heme oxygenase-1 gene expression by MAP kinases of the JNK and p38 pathways in primary cultures of rat hepatocytes.
    Kietzmann T; Samoylenko A; Immenschuh S
    J Biol Chem; 2003 May; 278(20):17927-36. PubMed ID: 12637567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase.
    Chang TS; Kim MJ; Ryoo K; Park J; Eom SJ; Shim J; Nakayama KI; Nakayama K; Tomita M; Takahashi K; Lee MJ; Choi EJ
    J Biol Chem; 2003 Nov; 278(48):48092-8. PubMed ID: 12963725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of the JNK and p38 MAPK pathway in c-Myc- and s-Myc-mediated apoptosis.
    Noguchi K; Yamana H; Kitanaka C; Mochizuki T; Kokubu A; Kuchino Y
    Biochem Biophys Res Commun; 2000 Jan; 267(1):221-7. PubMed ID: 10623602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of stress-responsive mitogen-activated protein (MAP) kinase pathways by TAO2.
    Chen Z; Cobb MH
    J Biol Chem; 2001 May; 276(19):16070-5. PubMed ID: 11279118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.